About Luceome Biotechnologies
Luceome Biotechnologies is a company based in Tucson (United States) founded in 2007.. Luceome Biotechnologies offers products and services including Cell-free KinaseSeeker Assays, Cell-based KinaseSeeker-TE Assays, and Custom Assay Development. Luceome Biotechnologies operates in a competitive market with competitors including Alamar Biosciences, Harmonic Discovery, Glympse Bio, Seahorse Bioscience and BiOD, among others.
- Headquarter Tucson, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Luceome Biotechnologies, L.L.C.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$240.43 K (USD), Grant
Apr 01, 2022
-
Investors
NIH
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Luceome Biotechnologies
Luceome Biotechnologies offers a comprehensive portfolio of products and services, including Cell-free KinaseSeeker Assays, Cell-based KinaseSeeker-TE Assays, and Custom Assay Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Profiles compound selectivity in vitro against kinase panels.
Evaluates compound target engagement inside cells for potency.
Tailors luciferase assays for in-house inhibitor screening needs.
Funding Insights of Luceome Biotechnologies
- Total Funding Total Funding
- Total Rounds 15
- Last Round Grant — $240,429
-
First Round
First Round
(01 Apr 2009)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Grant - Luceome Biotechnologies | Valuation |
investors |
|
| Dec, 2019 | Amount | Grant - Luceome Biotechnologies | Valuation |
investors |
|
| Mar, 2019 | Amount | Grant - Luceome Biotechnologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Luceome Biotechnologies
Luceome Biotechnologies has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Luceome Biotechnologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Luceome Biotechnologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Luceome Biotechnologies Comparisons
Competitors of Luceome Biotechnologies
Luceome Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alamar Biosciences, Harmonic Discovery, Glympse Bio, Seahorse Bioscience and BiOD, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ultra-high sensitivity protein analysis solutions are provided across multiplex levels.
|
|
| domain | founded_year | HQ Location |
Developer of kinase inhibitor drugs for oncology
|
|
| domain | founded_year | HQ Location |
Multiple human diseases are monitored noninvasively through urine-based analysis.
|
|
| domain | founded_year | HQ Location |
Cellular metabolic status is measured via the Seahorse XFp Analyzer.
|
|
| domain | founded_year | HQ Location |
Develops innovative in-vitro diagnostic platforms using optical interrogation of biochip-kits.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Luceome Biotechnologies
When was Luceome Biotechnologies founded?
Luceome Biotechnologies was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Where is Luceome Biotechnologies located?
Luceome Biotechnologies is headquartered in Tucson, United States. It is registered at Tucson, Arizona, United States.
What does Luceome Biotechnologies do?
Luceome Biotechnologies was founded in 2007 in Tucson, United States, within the biotechnology sector. Assay technology is developed for drug discovery targeting kinases. Solutions including KinaseSeeker and KinaseLite are provided, based on a platform using luciferase fragment complementation. Luminescence from this process is used to detect target interactions and off-target effects of drug candidates.
Who are the top competitors of Luceome Biotechnologies?
Luceome Biotechnologies's top competitors include Alamar Biosciences, Glympse Bio and Harmonic Discovery.
What products or services does Luceome Biotechnologies offer?
Luceome Biotechnologies offers Cell-free KinaseSeeker Assays, Cell-based KinaseSeeker-TE Assays, and Custom Assay Development.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.